Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-02-20 @ 10:12 PM
Study NCT ID:
NCT03304093
Status:
COMPLETED
Last Update Posted:
2023-05-12
First Post:
2017-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunotherapy by Nivolumab for HIV+ Patients
Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IFCT-1602
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER_GOV | View |